Chronic viral hepatitis accelerates lung function decline in smokers
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG..
Although hepatitis B virus (HBV) and hepatitis C virus (HCV) are hepatotrophic viruses, they may affect pulmonary diseases. The purpose of this study was to assess whether chronic viral hepatitis (CVH) infection was associated with a rapid decline in lung function. Repeated measurements of lung function were obtained from a well-curated health check-up database. A case was defined as an individual positive for HBsAg or anti-HCV antibody. A control was randomly selected (from the same dataset) after 1:1 matching in terms of age, sex, height, the body mass index, and smoking status. Separate analyses of non-smokers and smokers were performed. A total of 701 cases were enrolled (586 with HBV and 115 with HCV). In cross-sectional analysis, both forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) decreased significantly only in smokers (smoking cases vs. smoking controls) (adjusted p = 6.6 × 10-5 and adjusted p = 2.2 × 10-3, respectively). In longitudinal analysis, smoking cases showed significantly greater FEV1 and FVC decline rates than did smoking controls (adjusted p = 8.5 × 10-3 and adjusted p = 1.2 × 10-5, respectively). Such associations were particularly high in smoking cases at intermediate-to-high risk of hepatic fibrosis, as evaluated by the non-invasive Fibrosis-4 index. In summary, CVH was associated with both decreased lung function and accelerated lung function decline in smokers. A non-invasive measurement of hepatic fibrosis may be useful in predicting rapid lung function decline in smokers with CVH.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
---|---|
Enthalten in: |
Clinical and experimental medicine - 23(2023), 6 vom: 30. Okt., Seite 2159-2165 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lee, Suh-Young [VerfasserIn] |
---|
Links: |
---|
Themen: |
Chronic hepatitis B |
---|
Anmerkungen: |
Date Completed 02.10.2023 Date Revised 02.10.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s10238-022-00963-5 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM349618186 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM349618186 | ||
003 | DE-627 | ||
005 | 20231226043047.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10238-022-00963-5 |2 doi | |
028 | 5 | 2 | |a pubmed24n1165.xml |
035 | |a (DE-627)NLM349618186 | ||
035 | |a (NLM)36449120 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lee, Suh-Young |e verfasserin |4 aut | |
245 | 1 | 0 | |a Chronic viral hepatitis accelerates lung function decline in smokers |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 02.10.2023 | ||
500 | |a Date Revised 02.10.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG. | ||
520 | |a Although hepatitis B virus (HBV) and hepatitis C virus (HCV) are hepatotrophic viruses, they may affect pulmonary diseases. The purpose of this study was to assess whether chronic viral hepatitis (CVH) infection was associated with a rapid decline in lung function. Repeated measurements of lung function were obtained from a well-curated health check-up database. A case was defined as an individual positive for HBsAg or anti-HCV antibody. A control was randomly selected (from the same dataset) after 1:1 matching in terms of age, sex, height, the body mass index, and smoking status. Separate analyses of non-smokers and smokers were performed. A total of 701 cases were enrolled (586 with HBV and 115 with HCV). In cross-sectional analysis, both forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) decreased significantly only in smokers (smoking cases vs. smoking controls) (adjusted p = 6.6 × 10-5 and adjusted p = 2.2 × 10-3, respectively). In longitudinal analysis, smoking cases showed significantly greater FEV1 and FVC decline rates than did smoking controls (adjusted p = 8.5 × 10-3 and adjusted p = 1.2 × 10-5, respectively). Such associations were particularly high in smoking cases at intermediate-to-high risk of hepatic fibrosis, as evaluated by the non-invasive Fibrosis-4 index. In summary, CVH was associated with both decreased lung function and accelerated lung function decline in smokers. A non-invasive measurement of hepatic fibrosis may be useful in predicting rapid lung function decline in smokers with CVH | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Chronic hepatitis B | |
650 | 4 | |a Chronic hepatitis C | |
650 | 4 | |a Forced expiratory volume | |
650 | 4 | |a Respiratory function tests | |
650 | 4 | |a Smoking | |
650 | 4 | |a Trajectory | |
700 | 1 | |a Kim, Sun-Sin |e verfasserin |4 aut | |
700 | 1 | |a Lee, So-Hee |e verfasserin |4 aut | |
700 | 1 | |a Park, Heung-Woo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical and experimental medicine |d 2001 |g 23(2023), 6 vom: 30. Okt., Seite 2159-2165 |w (DE-627)NLM113691408 |x 1591-9528 |7 nnns |
773 | 1 | 8 | |g volume:23 |g year:2023 |g number:6 |g day:30 |g month:10 |g pages:2159-2165 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10238-022-00963-5 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 23 |j 2023 |e 6 |b 30 |c 10 |h 2159-2165 |